U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 212806

REGADENOSON (REGADENOSON)
0.4MG/5ML (0.08MG/ML)
Marketing Status: Prescription
Active Ingredient: REGADENOSON
Proprietary Name: REGADENOSON
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 0.4MG/5ML (0.08MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A212806
Product Number: 001
Approval Date: Apr 11, 2022
Applicant Holder Full Name: HONG KONG KING FRIEND INDUSTRIAL CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top